Benzofuran Hybrids as Cholinesterase (AChE and BChE) Inhibitors: In Vitro, In Silico, and Kinetic Studies
作者:I. Ali、R. Rafique、K. M. Khan、S. Chigurupati、X. Ji、A. Wadood、A. U. Rehman、U. Salar、N. M. Alyamani、S. Hameed、M. Taha、S. Hussain、S. Perveen
DOI:10.1134/s1068162022060061
日期:2022.12
degree of cholinesterase inhibitory potentials with IC50 value ranges for AChE (IC50 = (21.04 ± 0.51)–(87.17 ± 0.15) μM) and BChE (IC50 = (22.2 ± 0.15)–(90.17 ± 0.10) μM) on comparison with standard donepezil (AChE; IC50 = 19.08 ± 0.05 μM and BChE; IC50 = 19.58 ± 0.03 μM). Five compounds (IV) (AChE; IC50 = 21.04 ± 0.51 μM and BChE; IC50 = 22.2 ± 0.15 μM), (VI) (AChE; IC50 = 35.86 ± 0.23 μM and BChE; IC50
摘要 胆碱酯酶 (AChE 和 BChE) 在阿尔茨海默病 (AD) 之前的胆碱能缺陷中发挥重要作用。已观察到用小化合物抑制这些酶是治疗 AD 的一种有吸引力的方法。本研究揭示了苯并呋喃混合类似物对 AChE 和 BChE 酶的抑制活性。所有分子都表现出不同程度的胆碱酯酶抑制潜力, AChE (IC 50 = (21.04 ± 0.51)–(87.17 ± 0.15) μM) 和 BChE (IC 50 = (22.2 ± 0.15)–(90.17 ± 0.10)的 IC 50值范围μM)与标准多奈哌齐(AChE;IC 50 = 19.08 ± 0.05 μM 和 BChE;IC 50 = 19.58 ± 0.03 μM)比较。五种化合物(Ⅳ)(AChE;IC 50 = 21.04 ± 0.51 μM 和 BChE;IC 50 = 22.2 ± 0.15 μM),(VI)(AChE;IC